ArticleOncoimmunology2020

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response.

H Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.